![]() |
Formats:
|
||||||||||||||
Copyright © 2007 ELL & Excerpta Medica Inosine-Containing dsRNA Binds a Stress-Granule-like Complex and Downregulates Gene Expression In trans 1Department of Biochemistry, University of Cambridge, Cambridge CB2 1GA, UK A.D.J. Scadden: adjs/at/bioc.cam.ac.uk Corresponding author Email: adjs/at/bioc.cam.ac.ukReceived May 14, 2007; Revised July 5, 2007; Accepted September 6, 2007. This document may be redistributed and reused, subject to certain conditions. This document was posted here by permission of the publisher.
At the time of the deposit, it included all changes made during peer review,
copy editing, and publishing. The U. S. National Library of Medicine is responsible
for all links within the document and for incorporating any publisher-supplied
amendments or retractions issued subsequently. The published journal article,
guaranteed
to be such by Elsevier, is available for free, on ScienceDirect, at: http://dx.doi.org/10.1016/j.molcel.2007.09.005 Summary Long double-stranded RNAs (dsRNAs) may undergo extensive modification (hyperediting) by adenosine deaminases that act on RNA (ADARs), where up to 50% of adenosine (A) residues are changed to inosine (I). Traditionally, consequences of A-to-I editing were thought to be limited to modified RNA itself. We show here, however, that hyperedited dsRNA (I-dsRNA) is able to downregulate gene expression in trans. Furthermore, we show that both endogenous expression and reporter gene expression were substantially reduced in the presence of I-dsRNA. This was due to a reduction in reporter mRNA levels and also translation inhibition. Importantly, we show that I-dsRNA interferes with translation initiation. We also show that I-dsRNA specifically binds a stress-granule-like complex. Stress granules (SGs) are important for translational silencing during stress. Finally, we propose a model whereby editing by ADARs results in downregulation of gene expression via SG formation. Keywords: RNA Introduction Long double-stranded RNA (dsRNA) in cells is often indicative of viral infection (Maquat and Carmichael, 2001). Alternatively, it may result from expression of both sense and antisense RNAs, or from the presence of inverted repeat sequences within noncoding RNA. Cells respond to long dsRNA molecules by activating general antiviral systems mediated by enzymes such as PKR (Samuel, 1998). Alternatively, dsRNA may undergo covalent modification (editing) by adenosine deaminases that act on RNA (ADARs) (Bass, 2002), or be used in the RNAi pathway (Filipowicz et al., 2005). ADARs catalyze the hydrolytic deamination of adenosine (A) to inosine (I) (Bass, 2002). As I is decoded as guanosine (G) by ribosomes, selective editing has the potential to alter the coding capacity of mRNAs. ADARs also catalyze hyperediting within relatively long dsRNAs, where up to 50% of A residues are converted to I. Hyperediting changes not only the RNA sequence but also the structure, as IU and UI pairs have different geometry than AU and UA pairs (Serra et al., 2004). Localized distortions within the RNA helix are likely to result from the presence of IU pairs. The majority of mammalian editing occurs within noncoding regions of RNA, such as inverted repeat sequences within intronic or intergenic RNAs, or within untranslated regions (UTRs). The most frequent targets of editing are high copy number repetitive elements, such as Alus (Blow et al., 2004; Levanon et al., 2004; Morse et al., 2002). It has therefore been predicted that >85% of pre-mRNAs may be edited. A-to-I editing has also been found within miRNA precursors, which has the potential to affect both miRNA production and also target recognition (Blow et al., 2006; Kawahara et al., 2007; Yang et al., 2006). Hyperedited dsRNAs (I-dsRNAs) in cells may be subject to different fates. I-dsRNA may be retained in the nucleus by a protein complex comprising p54nrb, PSF, and matrin 3 (Zhang and Carmichael, 2001). Alternatively, hyperediting by ADARs could provide a means of covalently “tagging” dsRNA for subsequent disposal. We have previously identified a nuclease activity in various cytoplasmic extracts that specifically targets I-dsRNA (Scadden and Smith, 2001). Cleavage occurred within sequences containing multiple IU pairs, but not in duplexes that contained either isosteric GU pairs or Watson-Crick base pairs. Tudor staphylococcal nuclease (TSN), which is a component of the RNA-induced silencing complex in the RNAi pathway (Filipowicz et al., 2005), is important for cleavage of I-dsRNA (Scadden, 2005). Cleavage of I-dsRNA may play a role in viral defense or in destroying cellular dsRNAs edited by ADARs. During stress, eukaryotic cells have the ability to reprogram their ribosomes to selectively synthesize proteins needed for survival (Anderson and Kedersha, 2006). As part of this process, a subset of cellular mRNAs are translationally silenced by sequestration into cytoplasmic stress granules (SGs). As the mechanism underlying SG assembly appears to be impaired translation initiation (Anderson and Kedersha, 2006), SGs comprise stalled initiation complexes and small ribosomal proteins (Kedersha et al., 2002). When stress conditions are relieved, sequestered mRNAs may reassemble on polysomes to resume translation (Kedersha et al., 2000). Alternatively, mRNAs may be destroyed in cytoplasmic processing bodies (P bodies), which are dynamically linked to SGs (Kedersha et al., 2005). SGs therefore comprise sites of triage where mRNAs are sorted for storage, reinitiation, or degradation. Here we demonstrate that I-dsRNA specifically binds a complex that comprises proteins previously characterized as SG components. Furthermore, we show that I-dsRNA in cells results in downregulating both endogenous and reporter gene expression, in trans. We provide evidence that this is the result of both reduced mRNA levels and impaired translation. Moreover, we show that I-dsRNA inhibits translation initiation. We therefore propose a model in which hyperediting of dsRNAs by ADARs results in downregulation of gene expression via SG formation. Results I-dsRNA Binding Proteins dsRNA affinity matrices were previously used to identify specific I-dsRNA binding proteins, such as TSN (Scadden, 2005). We have now used a similar approach to identify additional I-dsRNA binding proteins. Briefly, X. laevis oocyte extract was incubated with a GU dsRNA affinity matrix to deplete nonspecific proteins, then with either a specific I-dsRNA (IU; Table 1) affinity matrix or a second GU dsRNA matrix (see Figure S1 in the Supplemental Data available with this article online). 2D-Dige was used to analyze proteins eluted from the final GU and IU matrices (Figure S1B), and I-dsRNA binding proteins were subsequently identified. Interestingly, most of these proteins were SG components (Figure 1
We next asked whether the specificity of binding of the X. laevis proteins to I-dsRNA was maintained in HeLa cell lysates. Specific (IU) or nonspecific (GU, C) dsRNAs were therefore used for HeLa cell affinity purification. Immunoblots were subsequently used to demonstrate that the I-dsRNA stress-complex proteins identified in X. laevis also bound preferentially to I-dsRNA in HeLa cell lysates (Figure 1 Formation of an HeLa protein complex on I-dsRNA could additionally be shown using electrophoretic mobility shift assays (EMSA) (Figure 1 I-dsRNA Reduced Expression of Luciferase Reporters As the I-dsRNA complex comprised SG proteins, we speculated that the presence of I-dsRNA in cells could induce SG formation, which would result in downregulating mRNA expression. To test this hypothesis, reporter plasmids and various synthetic dsRNAs (Table 1) were used to cotransfect HeLa cells. Short dsRNAs were used to avoid activation of PKR. Transfection conditions favored efficient uptake of the dsRNAs (>95% of cells), as judged by visualization of fluorescently labeled duplexes (data not shown). The first reporters tested were firefly (Pp-luc) and renilla luciferase (Rr-luc), together with the GP or IU dsRNAs (Table 1). The GP and IU duplexes were identical except for the four central base pairs; the GP control dsRNA consisted of perfect Watson-Crick base pairs, while the IU dsRNA contained IU pairs. The Pp-luc and Rr-luc reporters shared no sequence homology with each other, or with the dsRNAs. The reporter plasmids were cotransfected with either IU or GP into HeLa cells, and luciferase (luc) assays were carried out after 30 hr. In the presence of IU dsRNA, expression of both Pp-luc and Rr-luc was substantially reduced relative to that in the presence of GP (Figure 2
These data demonstrated conclusively that I-dsRNA was able to downregulate gene expression in a sequence-independent manner. Of particular interest was the observation that miR-142-IU caused reduced gene expression, which suggests that edited miRNAs have the potential for regulating gene expression in trans. IU Pairs Are Necessary for Reduced Expression To test whether IU pairs were required to reduce reporter expression or if I was sufficient per se, the IC dsRNA (Table 1) was tested in parallel with IU and GP, in conjunction with the luc reporters. IC differed from IU in that it contained IC pairs in the central region. When luc assays were performed following transfection of the various duplexes, only the IU duplex reduced Pp-luc and Rr-luc expression (Figure 2 Expression of GU Duplexes In Vivo Reduced Gene Expression We next asked whether dsRNAs transcribed within the cell rather than by transfection were also able to reduce reporter gene expression. Plasmids based on pSuper, which was designed for use in RNAi, were therefore constructed in order to produce dsRNAs equivalent to either C or C-IU in vivo. However, as both GU and IU dsRNAs inhibited luc expression (Figure 2 I-dsRNA Reduced Expression of GFP and β-Globin Reporters The expression of two additional reporters (GFP and β-globin) was next examined, in conjunction with two pairs of dsRNAs (C and C-IU, GP and IU). Again, the reporters and dsRNAs were unrelated. Gene expression was analyzed by immunoblotting. With the C and C-IU duplexes, expression of both GFP and β-globin was substantially reduced in the presence of C-IU relative to C dsRNA (Figure 2 I-dsRNA Reduced Endogenous Protein Synthesis We have shown conclusively that I-dsRNAs reduced expression of various reporter genes. We next asked whether I-dsRNA in cells also downregulated endogenous protein synthesis. To analyze the effect of I-dsRNA on endogenous protein synthesis, HeLa cells were transfected with either C or C-IU dsRNAs, then metabolically labeled with [35S]methionine ([35S]Met) 24 hr posttransfection. In the presence of the C-IU dsRNA, 20%–25% less [35S]Met was incorporated into newly synthesized endogenous proteins, relative to that seen with the control (C) duplex (Figure 2 I-dsRNAs Reduce mRNA Levels I-dsRNA caused a substantial reduction in expression of four different reporters, relative to control dsRNAs. We subsequently carried out experiments to see whether I-dsRNA affected reporter mRNA levels. Reverse transcription (RT) and quantitative PCR (qPCR) were initially used to analyze Pp-luc mRNA levels in experiments in which luc reporters were cotransfected with three different pairs of dsRNAs (C and C-IU, GP and IU, and miR-142 and miR-142-IU). The amount of mRNA in the presence of I-dsRNA was calculated relative to that seen with the non-I-dsRNA control, and normalized to GAPDH. For each pair of dsRNAs, the reporter mRNA was reduced in the presence of I-dsRNA (C-IU, IU, miR-142-IU, Figure 3
I-dsRNAs Cause Translational Inhibition While I-dsRNA caused a reduction in the level of reporter mRNAs (Figure 3 To address this question, we analyzed translation of Pp-luc reporter mRNA in vitro using micrococcal nuclease (MN)-treated rabbit reticulocyte lysate (RRL), in the presence of C or C-IU dsRNAs. Luc assays were subsequently used to quantify translation efficiency, and the Pp-luc activity was expressed as a percentage of the luc activity in the absence of dsRNA. In translation reactions using RRL alone, increasing amounts of C and C-IU dsRNAs had no effect on translation of Pp-luc mRNA (Figure 4
The translation inhibition observed with increasing concentrations of C-IU dsRNA was not the result of decreased stability of Pp-luc mRNA, as determined by RT/qPCR (Figure S4). These data demonstrated that I-dsRNA caused translational inhibition in vitro. I-dsRNA Reduced Translation of Endogenous mRNAs I-dsRNA inhibited translation of exogenous Pp-luc mRNA in vitro. We next asked whether translation of endogenous mRNAs in vitro was also reduced in the presence of C-IU dsRNA. We initially analyzed the effect of C-IU on translation of endogenous RRL globin mRNA. Translation reactions were therefore assembled using non-MN-treated RRL/S100, and [35S]Met was added to enable visualization of the translation products. In the presence of increasing concentrations of C-IU dsRNA, a corresponding decrease in translation of both Pp-luc and globin mRNA was seen (Figure 4 Translation of total HeLa mRNA was then analyzed using MN-treated RRL/S100, where [35S]Met was added to enable quantification. In the presence of increasing amounts of C-IU dsRNA, a corresponding decrease in translation of HeLa mRNA was observed, relative to that seen with C dsRNA (Figure 4 These data showed that I-dsRNA had an inhibitory effect on protein synthesis in vitro and were consistent with the observation that I-dsRNA resulted in downregulating protein synthesis in vivo (Figure 2 I-dsRNA Inhibited Initiation of Translation We have shown that I-dsRNA inhibited translation of many mRNAs. We therefore considered whether I-dsRNA interfered with either translation initiation or elongation. To investigate the effect of I-dsRNA on translation initiation, several reporter mRNAs were used for translation that differed in their requirement for initiation factors. These reporters depended on viral internal ribosome entry sites (IRESs) for recognition of the start codon, rather than cap-dependent ribosome scanning. The additional reporters used were poliovirus-Pp-luc (PV-Pp-luc), classical swine fever virus-Pp-luc (CSFV-Pp-luc), and cricket paralysis virus-Pp-luc (CrPV-Pp-luc). PV-Pp-luc requires all canonical factors except eIF4E; CSFV-Pp-luc does not require eIF4E, eIF4G, eIF4A, eIF4B, eIF1, or eIF1A; and CrPV-Pp-luc requires no canonical initiation factors. All of the luc reporters were capped and polyadenylated and were translated using MN-treated RRL/S100. The translation efficiency was measured by luc assays, as described above. As expected, addition of increasing amounts of C-IU dsRNA resulted in a corresponding decrease in translation of Pp-luc mRNA, while C dsRNA had no effect (Figure 4 Discussion To the best of our knowledge, the data presented here provide insights that suggest new roles for I-dsRNA. While the effects of A-to-I editing were previously thought to be restricted to the modified RNA itself, we now see that I-dsRNA is able to inhibit gene expression in trans (Figures 2–4 During cellular stress, up to 50% of mRNAs may be translationally silenced by sequestration in SGs (Anderson and Kedersha, 2006). Transiently transfected reporters may also be silenced by induction of SGs (Kedersha et al., 2000). Our findings that both endogenous protein synthesis and reporter gene expression are reduced in the presence of I-dsRNA (Figure 2 A key determinant for SG assembly is impaired translation initiation (Anderson and Kedersha, 2006). In view of the fact that I-dsRNA inhibits gene expression by interfering with translation initiation (Figure 4 I-dsRNA not only inhibits translation initiation but also results in reduced levels of reporter mRNAs (Figure 3 We have used model dsRNAs to show that I-dsRNA and GU dsRNA can downregulate gene expression (Figures 2 and 4 Cytoplasmic ADAR1 is induced by interferon (George and Samuel, 1999), which supports the idea that it is important for viral defense, and also in response to serum starvation (Wang et al., 2004). Moreover, ADAR1−/− mice were unviable, with extensive apoptosis in embryonic tissues normally expressing high levels of ADAR1 (Wang et al., 2004). Apoptosis similarly occurred in ADAR1−/− MEFs during serum starvation. Editing of an unknown substrate by ADAR1 was thought to be necessary for protection against stress-induced apoptosis. It is possible that I-dsRNA-induced SG assembly may facilitate cell survival during stress conditions. dADAR mutant flies had an increased resistance to reactive oxygen species (ROS) (Chen et al., 2004). This was the result of selective changes in gene expression, which included upregulation of two genes encoding potential ROS scavengers. Conversely, these genes were downregulated when dADAR was overexpressed. Changes in expression appeared to be indirectly regulated by dADAR. This is consistent with our model whereby editing results in reduced gene expression in trans. TSN interacts with and promotes specific cleavage of I-dsRNA (Scadden, 2005). We previously speculated that cleavage was important as part of an antiviral mechanism or to regulate aberrantly edited cellular dsRNAs. As TSN is an integral part of the I-dsRNA stress complex (Figure 1 We have put forward a provocative model whereby gene regulation occurs in response to A-to-I editing by ADARs. In accordance with this model, I-dsRNA has the potential to alter localization, stability or translation of mRNA, in trans. However, we cannot rule out the possibility that the observations made using I-dsRNA represent a more general quality control pathway in the cell that could be activated by other aberrantly structured RNAs. Future work will shed light on the scope of the proposed pathway. Experimental Procedures Transfections HeLa cells (2 × 105 cells/well) were transfected using Lipofectamine-2000 (Invitrogen). For cotransfection of dsRNA and DNA, 120 pmol dsRNA (80 pmol specific dsRNA + 40 pmol C dsRNA), and 0.2–1 μg DNA were used. Luciferase, 0.19 μg pGL3-con + 0.01 μg pRL-SV40 (Promega); GFP, 0.2 μg pEGFP-C1 (BD Biosciences); β-globin, 1 μg β-globin (βΔ5–7) + 0.2 μg Tat (Dye et al., 2006). For pSuper-C-GU and pSuper-C, cells were transfected with 1 μg DNA, then after 48 hr with luc reporters. Cells were harvested with TRI reagent (Sigma) for RNA, or passive lysis buffer (PLB; Promega) for luc assays. For immunoblots or IPs, cells were lysed in RIPA or NET buffer on ice for 25 min, and spun at 10,000 rpm for 10 min (4°C). Luciferase Assays Equal amounts of protein (determined by Bradford assays) were assayed using the Dual-Luciferase Reporter Assay System (Promega). Data shown are representative of multiple experiments (where all transfections were in triplicate) for each pair of dsRNAs, as indicated in figure legends. In Vitro Translation Assays comprised 45% RRL, 100 mM KCl, 0.5 mM MgCl2, 10 mM CP, 100 μM amino acids, and 25%–30% (v/v) HeLa S100 (or buffer E) (Scadden and Smith, 2001). Pp-luc mRNA (3 nM) and 0.5 μl of C or C-IU dsRNA (0–3 μM) were added. Where indicated, 50 ng HeLa mRNA, prepared using oligo(dT)25 dynabeads, was used. Reactions were incubated at 30°C for 90 min. [35S]Met (0.5 μl) was added for analysis by SDS-PAGE or TCA precipitation. Data were quantified using a Molecular Dynamics phosphorimager and Imagequant software. RT/qPCR DNase-treated RNA (2–5 μg) was used for RT using AMV-RT (Promega) and oligo dT. –RT controls were carried out. qPCR was done with a Rotor-Gene 6000 (Corbett Research) using SYBR green (Bioline). Fold change in mRNA levels was calculated relative to the control and normalized to GAPDH. See Supplemental Data for primers. dsRNA Affinity Matrices Affinity matrices comprised biotinylated dsRNAs (Dharmacon) linked to magnetic streptavidin beads (Dynal) and were incubated with lysates as described previously (Scadden, 2005). Proteins were eluted with ASB14 lysis buffer (8 M urea, 2% ASB14, protease inhibitors) and analyzed by 2D-DiGE. CyDye labeling, 2D protein separation, gel imaging, and analysis were performed as described previously (Karp et al., 2004). I-dsRNA binding proteins were identified by mass spectrometry (Scadden, 2005). HeLa dsRNA Affinity Purification HeLa cells were transfected with biotinylated dsRNAs. Cell lysates were prepared after 30 hr, and RNA complexes were recovered by incubation on ice with magnetic streptavidin beads. Beads were washed extensively with cold 10 mM HEPES-KOH/100 mM NaCl buffer, and proteins were eluted with SDS buffer. Metabolic Labeling HeLa cells were transfected using C or C-IU dsRNAs, then labeled 24 hr later with [35S]Met. For labeling, cells were incubated in Met-free media for 30 min, then [35S]Met (~3 MBq/ml) was added for a further 15 min. Cell lysates were prepared in RIPA buffer, and [35S]Met incorporation was quantified by TCA precipitation. Supplemental Data include Supplemental Experimental Procedures, Supplemental References, four figures, and one table and can be found with this article online at http://www.molecule.org/cgi/content/full/28/3/491/DC1/. Supplemental Data Document S1. Supplemental Experimental Procedures, Supplemental References, Four Figures, and One Table Click here to view.(179K, pdf) Acknowledgments I thank the Cambridge Centre for Proteomics, and N. Gray, N. Proudfoot, and S. Morley for reagents. I also thank C. Smith and R. Jackson for helpful comments. A.D.J.S. was funded by a Wellcome Trust RCDF. References Anderson and Kedersha, 2006. Anderson P., Kedersha N. RNA granules. J. Cell Biol. 2006;172:803–808. [PubMed] Bass, 2002. Bass B.L. RNA editing by adenosine deaminases that act on RNA. Annu. Rev. Biochem. 2002;71:817–846. [PubMed] Blow et al., 2004. Blow M., Futreal P.A., Wooster R., Stratton M.R. A survey of RNA editing in human brain. Genome Res. 2004;14:2379–2387. [PubMed] Blow et al., 2006. Blow M., Grocock R.J., van Dongen S., Enright A.J., Dicks E., Futreal P.A., Wooster R., Stratton M.R. RNA editing of human microRNAs. Genome Biol. 2006;7:R27. [PubMed] Chen et al., 2004. Chen L., Rio D.C., Haddad G.G., Ma E.B. Regulatory role of dADAR in ROS metabolism in Drosophila CNS. Brain Res. Mol. Brain Res. 2004;131:93–100. [PubMed] Dye et al., 2006. Dye M.J., Gromak N., Proudfoot N.J. Exon tethering in transcription by RNA polymerase II. Mol. Cell. 2006;21:849–859. [PubMed] Filipowicz et al., 2005. Filipowicz W., Jaskiewicz L., Kolb F.A., Pillai R.S. Post-transcriptional gene silencing by siRNAs and miRNAs. Curr. Opin. Struct. Biol. 2005;15:331–341. [PubMed] George and Samuel, 1999. George C.X., Samuel C.E. Characterization of the 5′-flanking region of the human RNA-specific adenosine deaminase ADAR1 gene and identification of an interferon-inducible ADAR1 promoter. Gene. 1999;229:203–213. [PubMed] Karp et al., 2004. Karp N.A., Kreil D.P., Lilley K.S. Determining a significant change in protein expression with DeCyder (TM) during a pair-wise comparison using two-dimensional difference gel electrophoresis. Proteomics. 2004;4:1421–1432. [PubMed] Kawahara et al., 2007. Kawahara Y., Zinshteyn B., Sethupathy P., Iizasa H., Hatzigeorgiou A.G., Nishikura K. Redirection of silencing targets by adenosine-to-inosine editing of miRNAs. Science. 2007;315:1137–1140. [PubMed] Kedersha et al., 2000. Kedersha N., Cho M.R., Li W., Yacono P.W., Chen S., Gilks N., Golan D.E., Anderson P. Dynamic shuttling of TIA-1 accompanies the recruitment of mRNA to mammalian stress granules. J. Cell Biol. 2000;151:1257–1268. [PubMed] Kedersha et al., 2002. Kedersha N., Chen S., Gilks N., Li W., Miller I.J., Stahl J., Anderson P. Evidence that ternary complex (eIF2-GTP-tRNA(i)(Met))-deficient preinitiation complexes are core constituents of mammalian stress granules. Mol. Biol. Cell. 2002;13:195–210. [PubMed] Kedersha et al., 2005. Kedersha N., Stoecklin G., Ayodele M., Yacono P., Lykke-Andersen J., Fitzler M.J., Scheuner D., Kaufman R.J., Golan D.E., Anderson P. Stress granules and processing bodies are dynamically linked sites of mRNP remodeling. J. Cell Biol. 2005;169:871–884. [PubMed] Levanon et al., 2004. Levanon E.Y., Eisenberg E., Yelin R., Nemzer S., Hallegger M., Shemesh R., Fligelman Z.Y., Shoshan A., Pollock S.R., Sztybel D. Systematic identification of abundant A-to-I editing sites in the human transcriptome. Nat. Biotechnol. 2004;22:1001–1005. [PubMed] Maquat and Carmichael, 2001. Maquat L.E., Carmichael G.G. Quality control of mRNA function. Cell. 2001;104:173–176. [PubMed] Masquida and Westhof, 2000. Masquida B., Westhof E. On the wobble GoU and related pairs. RNA. 2000;6:9–15. [PubMed] Morse et al., 2002. Morse D.P., Aruscavage P.J., Bass B.L. RNA hairpins in noncoding regions of human brain and Caenorhabditis elegans mRNA are edited by adenosine deaminases that act on RNA. Proc. Natl. Acad. Sci. USA. 2002;99:7906–7911. [PubMed] Sakamoto et al., 1999. Sakamoto K., Yamasaki Y., Kaneto H., Fujitani Y., Matsuoka T., Yoshioka R., Tagawa T., Matsuhisa M., Kajimoto Y., Hori M. Identification of oxidative stress-regulated genes in rat aortic smooth muscle cells by suppression subtractive hybridization. FEBS Lett. 1999;461:47–51. [PubMed] Samuel, 1998. Samuel C.E. Protein-nucleic acid interactions and cellular responses to interferon. Methods. 1998;15:161–165. [PubMed] Scadden, 2005. Scadden A.D.J. The RISC subunit Tudor-SN binds to hyper-edited double-stranded RNA and promotes its cleavage. Nat. Struct. Mol. Biol. 2005;12:489–496. [PubMed] Scadden and Smith, 2001. Scadden A.D.J., Smith C.W.J. Specific cleavage of hyper-edited dsRNAs. EMBO J. 2001;20:4243–4252. [PubMed] Serra et al., 2004. Serra M.J., Smolter P.E., Westhof E. Pronounced instability of tandem IU base pairs in RNA. Nucleic Acids Res. 2004;32:1824–1828. [PubMed] Wang et al., 2004. Wang Q.D., Miyakoda M., Yang W.D., Khillan J., Stachura D.L., Weiss M.J., Nishikura K. Stress-induced apoptosis associated with null mutation of ADAR1 RNA editing deaminase gene. J. Biol. Chem. 2004;279:4952–4961. [PubMed] Yang et al., 2006. Yang W.D., Chendrimada T.P., Wang Q.D., Higuchi M., Seeburg P.H., Shiekhattar R., Nishikura K. Modulation of microRNA processing and expression through RNA editing by ADAR deaminases. Nat. Struct. Mol. Biol. 2006;13:13–21. [PubMed] Zhang and Carmichael, 2001. Zhang Z., Carmichael G.G. The fate of dsRNA in the nucleus: a p54nrb-containing complex mediates the nuclear retention of promiscuously A-to-I edited RNAs. Cell. 2001;106:465–475. [PubMed] |
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||||||||||||
Cell. 2001 Jan 26; 104(2):173-6.
[Cell. 2001]Methods. 1998 Jul; 15(3):161-5.
[Methods. 1998]Annu Rev Biochem. 2002; 71():817-46.
[Annu Rev Biochem. 2002]Curr Opin Struct Biol. 2005 Jun; 15(3):331-41.
[Curr Opin Struct Biol. 2005]Annu Rev Biochem. 2002; 71():817-46.
[Annu Rev Biochem. 2002]Nucleic Acids Res. 2004; 32(5):1824-8.
[Nucleic Acids Res. 2004]Genome Res. 2004 Dec; 14(12):2379-87.
[Genome Res. 2004]Nat Biotechnol. 2004 Aug; 22(8):1001-5.
[Nat Biotechnol. 2004]Proc Natl Acad Sci U S A. 2002 Jun 11; 99(12):7906-11.
[Proc Natl Acad Sci U S A. 2002]Genome Biol. 2006; 7(4):R27.
[Genome Biol. 2006]Science. 2007 Feb 23; 315(5815):1137-40.
[Science. 2007]Cell. 2001 Aug 24; 106(4):465-75.
[Cell. 2001]EMBO J. 2001 Aug 1; 20(15):4243-52.
[EMBO J. 2001]Curr Opin Struct Biol. 2005 Jun; 15(3):331-41.
[Curr Opin Struct Biol. 2005]Nat Struct Mol Biol. 2005 Jun; 12(6):489-96.
[Nat Struct Mol Biol. 2005]J Cell Biol. 2006 Mar 13; 172(6):803-8.
[J Cell Biol. 2006]Mol Biol Cell. 2002 Jan; 13(1):195-210.
[Mol Biol Cell. 2002]J Cell Biol. 2000 Dec 11; 151(6):1257-68.
[J Cell Biol. 2000]J Cell Biol. 2005 Jun 20; 169(6):871-84.
[J Cell Biol. 2005]Nat Struct Mol Biol. 2005 Jun; 12(6):489-96.
[Nat Struct Mol Biol. 2005]J Cell Biol. 2006 Mar 13; 172(6):803-8.
[J Cell Biol. 2006]Nat Struct Mol Biol. 2005 Jun; 12(6):489-96.
[Nat Struct Mol Biol. 2005]Nat Struct Mol Biol. 2006 Jan; 13(1):13-21.
[Nat Struct Mol Biol. 2006]J Cell Biol. 2006 Mar 13; 172(6):803-8.
[J Cell Biol. 2006]J Cell Biol. 2000 Dec 11; 151(6):1257-68.
[J Cell Biol. 2000]J Cell Biol. 2006 Mar 13; 172(6):803-8.
[J Cell Biol. 2006]J Cell Biol. 2005 Jun 20; 169(6):871-84.
[J Cell Biol. 2005]RNA. 2000 Jan; 6(1):9-15.
[RNA. 2000]Annu Rev Biochem. 2002; 71():817-46.
[Annu Rev Biochem. 2002]Genome Res. 2004 Dec; 14(12):2379-87.
[Genome Res. 2004]Genome Biol. 2006; 7(4):R27.
[Genome Biol. 2006]Nat Biotechnol. 2004 Aug; 22(8):1001-5.
[Nat Biotechnol. 2004]Gene. 1999 Mar 18; 229(1-2):203-13.
[Gene. 1999]J Biol Chem. 2004 Feb 6; 279(6):4952-61.
[J Biol Chem. 2004]Brain Res Mol Brain Res. 2004 Nov 24; 131(1-2):93-100.
[Brain Res Mol Brain Res. 2004]Nat Struct Mol Biol. 2005 Jun; 12(6):489-96.
[Nat Struct Mol Biol. 2005]FEBS Lett. 1999 Nov 12; 461(1-2):47-51.
[FEBS Lett. 1999]Mol Cell. 2006 Mar 17; 21(6):849-59.
[Mol Cell. 2006]EMBO J. 2001 Aug 1; 20(15):4243-52.
[EMBO J. 2001]Nat Struct Mol Biol. 2005 Jun; 12(6):489-96.
[Nat Struct Mol Biol. 2005]Proteomics. 2004 May; 4(5):1421-32.
[Proteomics. 2004]